Literature DB >> 9633693

Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22.

C L Lendon1, T Lynch, J Norton, D W McKeel, F Busfield, N Craddock, S Chakraverty, G Gopalakrishnan, S D Shears, W Grimmett, K C Wilhelmsen, L Hansen, J C Morris, A M Goate.   

Abstract

OBJECTIVE: The clinical and pathologic features of hereditary dysphasic disinhibition dementia (HDDD) are described to determine whether it is a variant of known dementias.
BACKGROUND: Several dementing disorders have clinical and pathologic similarities with AD, Pick's disease, and the "nonspecific" dementias. A detailed description of clinical and pathologic presentation will aid classification, but ultimately the discovery of causative gene(s) will define these disorders.
METHODS: The authors performed a clinical assessment: gross and microscopic pathologic evaluation of brain tissue, genetic linkage studies, and sequence analyses.
RESULTS: HDDD is an autosomal-dominant frontotemporal dementia with many similarities to Pick's disease. Salient clinical features are global dementia with disproportionate dysphasia and "frontotemporal" symptoms. A linkage between HDDD and 17q21-22 was shown, with a maximum lod score of 3.68 at zero recombination.
CONCLUSIONS: Several dementias have been linked to the same region and have been termed frontotemporal dementia with parkinsonism linked to chromosome 17. These disorders may represent phenotypic variants arising from mutations within a common gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633693     DOI: 10.1212/wnl.50.6.1546

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

1.  The tangled biology of tau.

Authors:  K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

3.  Frontotemporal dementia classification and neuropsychiatry.

Authors:  Tiffany W Chow; Bruce L Miller; Kyle Boone; Fred Mishkin; Jeffrey L Cummings
Journal:  Neurologist       Date:  2002-07       Impact factor: 1.398

4.  Absence of pathogenic mutations in presenilin homologue 2 in a conclusively 17-linked tau-negative dementia family.

Authors:  R Rademakers; M Van den Broeck; K Sleegers; C van Duijn; C Van Broeckhoven; M Cruts
Journal:  Neurogenetics       Date:  2003-10-08       Impact factor: 2.660

Review 5.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

6.  Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.

Authors:  Kevin F Bieniek; Melissa E Murray; Nicola J Rutherford; Monica Castanedes-Casey; Mariely DeJesus-Hernandez; Amanda M Liesinger; Matthew C Baker; Kevin B Boylan; Rosa Rademakers; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-09-28       Impact factor: 17.088

7.  Frontotemporal dementia in a large Swedish family is caused by a progranulin null mutation.

Authors:  Lena Skoglund; RoseMarie Brundin; Tommie Olofsson; Hannu Kalimo; Sofie Ingvast; Elin S Blom; Vilmantas Giedraitis; Martin Ingelsson; Lars Lannfelt; Hans Basun; Anna Glaser
Journal:  Neurogenetics       Date:  2008-10-15       Impact factor: 2.660

8.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Authors:  P Rizzu; J C Van Swieten; M Joosse; M Hasegawa; M Stevens; A Tibben; M F Niermeijer; M Hillebrand; R Ravid; B A Oostra; M Goedert; C M van Duijn; P Heutink
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

Authors:  Chiara Fenoglio; Daniela Galimberti; Francesca Cortini; John S K Kauwe; Carlos Cruchaga; Eliana Venturelli; Chiara Villa; Maria Serpente; Diego Scalabrini; Kevin Mayo; Laura M Piccio; Francesca Clerici; Diego Albani; Claudio Mariani; Gianluigi Forloni; Nereo Bresolin; Alison M Goate; Elio Scarpini
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Authors:  Jianhua Zhou; Qingming Yu; Tie Zou
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.